A Study of Human Umbilical Cord Blood (REGENECYTE) Infusion in Patients With Post-COVID Condition

NCT07184385 · clinicaltrials.gov ↗

PHASE3

Phase

NOT_YET_RECRUITING

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Long COVID
Post-COVID-19 Condition
Post-COVID Syndrome
Post-COVID Condition

Interventions

BIOLOGICAL: REGENECYTE
BIOLOGICAL: Placebo

Sponsor

StemCyte, Inc.